Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Maybe a new CEO and jail time can push him out of the picture for good. Then at last there would be some hope.
Still holding after all these years….
They were bitten by Costello and now are the moderators of this board. I get it. But there is still value here and Costello has been marginalized. I'm still hopeful.
Yeah I heard you the first thousand times.
Strange, we have a good PR and price tanks.
Wonder why.
Yes we know about the scam claims but nothing new there.
Anyone with insights please share.
Will be interesting to see if HPST is now off the table for RNWF because of this. The leadership has distanced itself from JC and company.
Because it's a shell and has been for a while. They haven't been involved in fuels for a long time but have positioned themselves for a reverse merger.
Redskin and Viking, good to see you guys still here. Hopefully no JenGrey this time. Please share if you hear anything and I will too.
Thanks H8ster, you are always on the ball!
I submitted a complaint but don't have high hopes.
Great! Thanks H8ster as always!
Thanks as always!
Where are you getting this info?
Thanks NoChance, you have always been a positive force for us!
Thanks for working on this. I'll put my millions of shares behind you if you need them.
I'll go halfsies with you on the web update.
When does it expire?
NewCardio Board of Directors Elects Patrick Maguire Chairman
SANTA CLARA, Calif., June 23, 2011 /PRNewswire/ -- NewCardio, Inc., (OTC BB: NWCI) a cardiac diagnostic technology provider, announced today that Patrick Maguire, MD, PhD, member of the NewCardio board of directors since March of 2008 and a proven leader and a seasoned executive with experience in a variety of leadership roles with companies involved in medical devices and pharmaceuticals, has been elected Chairman of NewCardio's Board of Directors, effective immediately. Mark W. Kroll, PhD, FACC, FHRS, NewCardio's previous chairman, will remain a director.
Dr. Maguire has served as the Chief Executive Officer and President of CyberHeart Inc. since 2006. He joined CyberHeart following the acquisition of the oncology assets of Targent Incorporated, where Dr. Maguire served as President, CEO, and Director since 2002. Prior to joining Targent, Dr. Maguire was Vice President of Medical Affairs and Technology Development at VitaGen Incorporated, where he oversaw the preparation of IND's, NDA's, and IDE's and managed VitaGen's clinical trials in acute and chronic liver failure as well as medical and industry collaborations. He is a cardiovascular and thoracic surgeon and has acted as a principal investigator for medical devices and associated clinical trials. Dr. Maguire is a fellow of the American and Royal College of Surgeons and a member of more than 20 medical, academic and business societies. He received an AB degree from Wesleyan University, an MD and PhD (Physiology and Biophysics) degrees from Georgetown University and an MBA degree from Pepperdine University. He completed surgical and cardiovascular fellowships at The Peter Bent Brigham Hospital, Harvard University, and Stanford University.
Dr. Maguire commented, "I continue to believe NewCardio possesses superior technology to address both the cardiac safety and arrhythmia monitoring markets. I look forward to being part of continued progress and success. On behalf of the board, I'd like to extend my gratitude to Dr. Kroll for his years of leadership as chairman, and we look forward to his continued input and guidance as a member of the board."
Dr. Kroll commented, "Dr. Maguire has an impressive educational and professional background and has been a major contributor to our board. I look forward to serving with him during his term as chairman."
About NewCardio, Inc.
NewCardio is a cardiac diagnostic and services company developing and marketing proprietary software platform technologies to provide higher accuracy to, and increase the value of, the standard 12-lead ECG. NewCardio's 3D ECG software platform reduces the time and expense involved in assessing cardiac status while increasing the ability to diagnose clinically significant conditions which were previously difficult to detect. NewCardio's software products and services significantly improve the diagnosis and monitoring of cardiovascular disease, as well as cardiac safety assessment of drugs under development. For more information, visit www.newcardio.com.
Forward-Looking Statements
This press release contains forward-looking statements. Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates and projections about our business based on currently available information and assumptions made by management. Although we believe that the assumptions on which the forward-looking statements contained herein are based are reasonable, any of those assumptions could prove to be inaccurate given the inherent uncertainties as to the occurrence or nonoccurrence of future events. These statements are not guarantees of future performance and involve risks and uncertainties that are difficult to predict. Therefore, actual outcomes and results may, and are likely to, differ materially from what is expressed or forecasted in the forward-looking statements due to numerous factors, including the potential risks and uncertainties set forth in Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2010 and relate to our business plan, our business strategy, development of our proprietary technology platform and our products, timing of such development, timing and results of clinical trials, level and timing of FDA regulatory clearance or review, market acceptance of our products, protection of our intellectual property, implementation of our strategic, operating and people initiatives, benefits to be derived from personnel and directors, ability to commercialize our products, our assumptions regarding cash flow from operations and cash on-hand, the amount and timing of operating costs and capital expenditures relating to the expansion of our business, operations and infrastructure, implementation of marketing programs, our key agreements and strategic alliances, our ability to obtain additional capital as, and when, needed, and on acceptable terms and general economic conditions specific to our industry, any of which could impact sales, costs and expenses and/or planned strategies and timing. We assume no obligation to, and do not currently intend to, update these forward-looking statements.
To join our email distribution please click this link: http://www.b2i.us/irpass.asp?BzID=1645&to=ea&s=0
Investor Contact:
Hayden Communications, Inc.
Jeff Stanlis, VP of Communications
(602) 476-1821 begin_of_the_skype_highlighting (602) 476-1821 end_of_the_skype_highlighting
jeff@haydenir.com
Great job guys, thanks!
Thanks so much NoChance!
Not to be a pessimist, but I doubt the company is doing anything. I would not hold off on a move while waiting for the company. Whatever you think you can do yourself, go for it. I am behind you all the way and willing to help!
Without current filings wouldn't a R/M not be possible?
Thanks for working on this, happy to help in any way I can.
Another 911 trade. So stupid. Wish we could get it moving!
Anyone have a guess why its moving up with increased volume? No Jengrey in the house...
Let's hope so Red, we certainly need a good run!
Thanks for the hard work!
I've talked to the transfer agent once before (can't remember if it's Worldwide, I have it in my office). I will try them again in the next day or two.
Yeah, but I'm still stuck holding. Not even worth it to get out now...
The problem is that despite all these connections and ventures, I can never get anyone on the phone (I've been trying on and off for a month or so). All of these companies just have answering machines. Uram agreed that they are unreachable, which leaves us in the dark....
Would be so great if MOP could take advantage of reports like this:
http://hosted.ap.org/dynamic/stories/U/US_GULF_OIL_SPILL?SITE=MIDTN&SECTION=HOME&TEMPLATE=DEFAULT
Looks like I'm a bagholder again with my 10+ million shares. I will call Mark again within the next week to see if he has any other thoughts, unless someone else wants to call. Meanwhile, hoping for a miracle...
Quadruple normal volume. Hmmm.... Maybe something doing besides just end of year stuff? Hope so!
I've been calling and still just get voicemails. Here are the numbers I've been trying:
David Miller at Phoenix Investors LLC (414) 283-2600
Frank Crivello at Crivello Group LLC (954) 532-0320 (also listed as Southeast Regional Office of Phoenix Investors LLC)
I've called 4 times in the past week or so at different times of day. I have not been leaving messages.
I know it's not progress, but wanted to update folks.
Anyone live near Milwaukee WI or Port Canaveral FL?
FWIW, he told me "no" yesterday.
When I talked to Mark today I definitely got the sense that he knew there was leadership out there (not him) and they were non-responsive. Just my sense of the conversation...
Red, thanks for the nice PM, sorry I can't PM back, I have the crappy free account. Yes, I'm holding 12 million shares.
Sorry, no. I was more interested in trying to track down the leadership. Can you try them tomorrow?
WorldWide Stock Transfer, LLC
433 Hackensack Ave, Level - L
Hackensack, NJ 07601
Phone: (201) 820-2008
Fax: (201) 820-2010
I will keep working on David M. Marks at Phoenix Investors LLC.
Looks like david@phoenixinv.com is
David M. Marks
Phoenix Investors, LLC
1818 North Farwell Avenue
Milwaukee, Wisconsin 53202
Phone: (414) 283-2600
Facsimile: (414) 283-2610
Called the number, put in his info, and got voicemail.
I'll keep trying.
I called Interwest Transfer Co, they are no longer transfer agent, they were when it was Tech. Labs.
Based on an old ihub post I called
WorldWide Stock Transfer, LLC
433 Hackensack Ave, Level - L
Hackensack, NJ 07601
Phone: (201) 820-2008
Fax: (201) 820-2010
They are the transfer agent. The only contact info they had was an email: david@phoenixinv.com
However, he said noone responds to when they write to this email. I will still try it.
Can't be good if RNWF doesn't respond to their own TA.
Guess I'm still a bagholder.
Called Yorkville Advisors (YA Global), spoke to Sam then Carl. Carl works on investment in renewable energy. He said he thought Renewal Fuels went under. When I said they still had a ticker and investors, he said whoever was involved with that investment from YA Global would no longer with the company. I asked if they still had money in RNWF and he said he would not know.
Sorry, not too helpful but I will keep at it.
Just spoke to Mark Uram who says he is still holding. He also has not had success reaching the folks in Milwaukee or YA Global. I asked his advice about what we should do as shareholders and he recommended continuing to reach the Milwaukee folks on the last filing and/or YA Global. I will work on that today or tomorrow.